Clinical evaluation reveals therapeutic resistance in G-CSF-producing lung cancer with EGFR mutations, highlighting substantial treatment challenges.
Granulocyte colony-stimulating factor (G-CSF)-producing neoplasms are relatively rare; however, little is known on the clinical features of G-CSF-producing lung cancer harboring activating epidermal growth factor receptor (EGFR) mutations.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: